Page last updated: 2024-08-22

(1S,2R)-tranylcypromine and tretinoin

(1S,2R)-tranylcypromine has been researched along with tretinoin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Lan, F; Liu, R; Xu, S; Xu, Y; Zha, X; Zhou, C; Zhu, Q	1

Other Studies

2 other study(ies) available for (1S,2R)-tranylcypromine and tretinoin

Article	Year
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia. Bioorganic & medicinal chemistry, 2018, 09-15, Volume: 26, Issue:17 Topics: Antineoplastic Agents; Barbiturates; Cell Line, Tumor; DNA Methylation; Enzyme Inhibitors; Histone Demethylases; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Spectrum Analysis	2018

Article

Year

Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.

Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012

Optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia.

Bioorganic & medicinal chemistry, 2018, 09-15, Volume: 26, Issue:17

Topics: Antineoplastic Agents; Barbiturates; Cell Line, Tumor; DNA Methylation; Enzyme Inhibitors; Histone Demethylases; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Spectrum Analysis

2018